We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Process for Dispute Resolution Above The Divisional Level Clarified by U.S FDA
Process for Dispute Resolution Above The Divisional Level Clarified by U.S FDA
The U.S. Food and Drug Administration is clarifying when drugmakers can seek dispute resolution above the divisional level, citing five regulatory actions that are appropriate for a formal dispute resolution request.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor